Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
Journal of Cellular and Molecular Medicine|October 1, 2019
Non-lethal proteasome inhibition activates pro-tumorigenic pathways in multiple myeloma cellsAikaterini Skorda, Aimilia D Sklirou, Theodore Sakellaropoulos, et al.
Toxicology and Applied Pharmacology|April 14, 2009
Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicityBenjamin D Cosgrove, Bracken M King, Maya A Hasan, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2000
A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer. European Lung Cancer Working PartyJ P Sculier, M Paesmans, J Thiriaux, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2007
A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancerJ P Sculier, J J Lafitte, J Lecomte, et al.
Kidney International|May 29, 2021
Cadherin-11, Sparc-related modular calcium binding protein-2, and Pigment epithelium-derived factor are promising non-invasive biomarkers of kidney fibrosisInsa M Schmidt, Mia R Colona, Bryan R Kestenbaum, et al.
Scientific Reports|March 24, 2021
Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assaysChristos Fotis, Nikolaos Meimetis, Nikos Tsolakos, et al.
Plos Computational Biology|October 27, 2017
Dynamics and heterogeneity of brain damage in multiple sclerosisEkaterina Kotelnikova, Narsis A Kiani, Elena Abad, et al.
British Journal of Cancer|May 3, 2007
Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working PartyT Berghmans, J J Lafitte, J Lecomte, et al.
Bioinformatics (Oxford, England)|October 9, 2014
A crowd-sourcing approach for the construction of species-specific cell signaling networksErhan Bilal, Theodore Sakellaropoulos, Ioannis N Melas, et al.
Genome Medicine|July 17, 2021
Prediction of combination therapies based on topological modeling of the immune signaling network in multiple sclerosisMarti Bernardo-Faura, Melanie Rinas, Jakob Wirbel, et al.
Pageof 16